Composition Each tablet contains ethamsylate 250 mg. Pharmacokinetics Ethamsylate is absorbed from the gastro-intestinal tract when given orally. It produce its effect within one hour. It is excreted unchanged mainly in the urine, some appears in the faeces and bile. Indications For the prophylaxis and control of haemorhage due to rupture of small blood vessels …
Haemostat 250 mg Tablets: Anti-fibrinolytic & Haemostatics Read More »
Composition Each tablet or 5 ml ampoule contains: 500 mg Tranexamic acid. Clinical pharmacology Kapron® (Tranexamic acid) is an antifibrinolytic drug, acting by competitively inhibiting the activation of plasminogen to plasmin. Kapron® stabilizes the fibrin structures, as defective fibrin formation or excessive rapid dissolution of fibrin results n excessive or recurrent bleeding, and that is through …
Composition Each 2 ml ampoule contains ethamsylate 250 mg Each tablet contains ethamsylate 250 mg Properties Ethamsylate (Haemostop®) is a non-hormonal synthetic anti-haemorrhagic agent, for improving the platelet adhesiveness and maintaining the stability of capillary wall. Ethamsylate (Haemostop®) reduces rapidlyand substantially the bleeding time (40-45% after the first half-hour). Its effect remains at a therapeutic …
Composition Each 1 ml ampoule contains: Phytomenadione 10 mg. Each tablet contains: Phytomenadione 10 mg Properties Haemokion® (Phytomenadione) is a lipid soluble synthetic analogue of vitamin k1 having the same type and degree of activity as the naturally occurring vitamin k1. Haemokion® is necessary for the synthesis of blood coagulation factors II, VII, IX and …